Emergence of keratin 17 vs. loss of keratin 13: Their reciprocal immunohistochemical profiles in oral carcinoma in situ

Oral Oncology

Volumn 47, Issue 6, 2011, Pages 497-503

  Mikami, Toshihiko ^a   Cheng, Jun ^a   Maruyama, Satoshi ^b   Kobayashi, Takanori ^b   Funayama, Akinori ^a   Yamazaki, Manabu ^a   Adeola, Henry A ^a   Wu, Lanyan ^c   Shingaki, Susumu ^a   Saito, Chikara ^a   Saku, Takashi ^a,b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Carcinoma in situ; Epithelial dysplasia; Keratin 13; Keratin 17; Oral mucosa

Indexed keywords

CYTOKERATIN 13; CYTOKERATIN 17;

ARTICLE; CANCER INVASION; CARCINOMA IN SITU; EPITHELIUM DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MOUTH CARCINOMA; MOUTH LESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-13; KERATIN-17; MOUTH MUCOSA; PRECANCEROUS CONDITIONS;

EID: 79958026072     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.03.015     Document Type: Article

References (36)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6(5):963-8.
2. van Oijen MG, Slootweg PJ. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev 2000;9(3):249-56.
3. Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology, molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 2006;5:11.
4. Gillenwater A, Papadimitrakopoulou V, Richards-Kortum R. Oral premalignancy: new methods of detection and treatment. Curr Oncol Rep 2006;8(2):146-54.
5. Bouquot JE, Speight PM. Farthing PM: epithelial dysplasia of the oral mucosa - diagnostic problems and prognostic features. Curr Diagn Pathol 2006;12(1):11-2.
6. Rhiner C. Moreno E: super competition as a possible mechanism to pioneer precancerous fields. Carcinogenesis 2009;30(5):723-8.
7. Johnston LA. Competitive interactions between cells: death, growth, and geography. Science 2009;324(5935):1679-82.
8. Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med 2009;38(10):737-52.
9. Kobayashi T, Maruyama S, Cheng J, Ida-Yonemochi H, Yagi M, Takagi R, et al. Diagnosis aided by immunohistochemistry dealing with the second basal cell layer as the proliferating center of oral mucosal epithelia. Pathol Int 2010;60(3):156-66.
10. Alvarado CG, Maruyama S, Cheng J, Ida-Yonemochi H, Kobayashi T, Yamazaki M, et al. Nuclear translocation of b-catenin synchronized with loss of Ecadherin in oral epithelial dysplasia with a characteristic two-phase appearance. Histopathology, in press.
11. Tilakaratne WM, Kobayashi T, Ida-Yonemochi H, Swelam W, Yamazaki M, Mikami T, et al. Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers. J Oral Pathol Med 2009;38(4):348-55.
12. Funayama A, Cheng J, Maruyama S, Yamazaki M, Kobayashi T, Syafriadi M, et al. Enhanced expressions of podoplanin in oral carcinoma in-situ and squamous cell carcinoma. Pathobiology 2011;78. doi:10.1159/000324926.
13. Troyanovsky SM, Guelstein VI, Tchipysheva TA, Krutovskikh VA. Bannikov GA: patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci 1989;93(Pt 3):419-26. (Pubitemid 19188086)
14. Smedts F, Ramaekers F, Troyanovsky S, Pruszczynski M, Link M, Lane B, et al. Keratin expression in cervical cancer. Am J Pathol 1992;141(2):497-511.
15. Takahashi H, Shikata N, Senzaki H, Shintaku M, Tsubura A. Immunohistochemical staining patterns of keratins in normal oesophageal epithelium and carcinoma of the oesophagus. Histopathology 1995;26(1):45-50.
16. Cohen-Kerem R, Madah W, Sabo E, Rahat MA, Greenberg E, Elmalah I. Cytokeratin-17 as a potential marker for squamous cell carcinoma of the larynx. Ann Otol Rhinol Laryngol 2004;113(10):821-7. (Pubitemid 39362228)
17. Bloor BK, Seddon SV, Morgan PR. Gene expression of differentiation- specific keratins in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncol 2001;37(3):251-61. (Pubitemid 32245849)
18. Syafriadi M, Cheng J, Jen KY, Ida-Yonemochi H, Suzuki M, Saku T. Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells. J Oral Pathol Med 2005;34(3):140-9. (Pubitemid 40293222)
19. Ivanyi D, Minke JM, Hageman C, Groeneveld E, van Doornewaard G, Misdorp W. Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas. Am J Vet Res 1993;54(7):1095-102.
20. Smith FJ, Jonkman MF, van Goor H, Coleman CM, Covello SP, Uitto J, et al. A mutation in human keratin k6b produces a phenocopy of the k17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998;7(7):1143-8. (Pubitemid 28306880)
21. Troyanovsky SM, Leube RE, Franke WW. Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol 1992;59(1):127-37.
22. Moll R, Moll I, Franke WW. Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res 1984;276(6):349-63. (Pubitemid 14035108)
23. McGowan KM, Coulombe PA. Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. J Cell Biol 1998;143(2):469-86. (Pubitemid 28487864)
24. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol 2001;116(5):633-40. (Pubitemid 32467639)
25. de Jong EM, van Vlijmen IM, van Erp PE, Ramaekers FC, Troyanovski SM, Van de Kerkhof PC. Keratin 17: A useful marker in anti-psoriatic therapies. Arch Dermatol Res 1991;283(7):480-2.
26. Coffey Jr RJ, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, et al. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature 1987;328(6133):817-20. (Pubitemid 17125960)
27. Wetzels RH, Schaafsma HE, Leigh IM, Lane EB, Troyanovsky SM, Wagenaar SS, et al. Laminin and type vii collagen distribution in different types of human lung carcinoma: Correlation with expression of keratins 14, 16, 17 and 18. Histopathology 1992;20(4):295-303.
28. Ohkura S, Kondoh N, Hada A, Arai M, Yamazaki Y, Sindoh M, et al. Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol 2005;41(6):607-13. (Pubitemid 40828878)
29. Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW, Ries J. Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma. J Cancer Res Clin Oncol 2008;134(4):515-21.
30. Wei KJ, Zhang L, Yang X, Zhong LP, Zhou XJ, Pan HY, et al. Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo. Oral Dis 2009;15(1):111-7.
31. Ikeda K, Tate G, Suzuki T, Mitsuya T. Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: An immunohistochemical analysis and review of the literature. Gynecol Oncol 2008;108(3):598-602.
32. Morgan PR, Shirlaw PJ, Johnson NW, Leigh IM, Lane EB. Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol 1987;16(4):212-22.
33. Regauer S, Reich O. Ck17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology 2007;50(5):629-35.
34. Kim S, Wong P, Coulombe PA. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 2006;441(7091):362-5. (Pubitemid 44050202)
35. Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol 2003;23(20): 7096-107. (Pubitemid 37210993)
36. Xu G, Zhang W, Bertram P, Zheng XF, McLeod H. Pharmacogenomic profiling of the pi3k/pten-akt-mtor pathway in common human tumors. Int J Oncol 2004;24(4):893-900.